NZ571119A - Use of tris(hydroxyquinolinolato)gallium(III) for the treatment of melanomas - Google Patents

Use of tris(hydroxyquinolinolato)gallium(III) for the treatment of melanomas

Info

Publication number
NZ571119A
NZ571119A NZ571119A NZ57111907A NZ571119A NZ 571119 A NZ571119 A NZ 571119A NZ 571119 A NZ571119 A NZ 571119A NZ 57111907 A NZ57111907 A NZ 57111907A NZ 571119 A NZ571119 A NZ 571119A
Authority
NZ
New Zealand
Prior art keywords
gallium
melanoma
hydroxyquinolinolato
tris
medicament
Prior art date
Application number
NZ571119A
Other languages
English (en)
Inventor
Bernhard Keppler
Original Assignee
Niiki Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Niiki Pharma Inc filed Critical Niiki Pharma Inc
Publication of NZ571119A publication Critical patent/NZ571119A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Quinoline Compounds (AREA)
NZ571119A 2006-02-13 2007-02-13 Use of tris(hydroxyquinolinolato)gallium(III) for the treatment of melanomas NZ571119A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0022006A AT503317B1 (de) 2006-02-13 2006-02-13 Verwendung von gallium(iii)-komplexen zur herstellung eines medikaments zur behandlung von melanomen
PCT/AT2007/000071 WO2007092978A1 (de) 2006-02-13 2007-02-13 Verwendung von gallium (iii) komplexen zur behandlung von melanomen

Publications (1)

Publication Number Publication Date
NZ571119A true NZ571119A (en) 2011-11-25

Family

ID=37969931

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ571119A NZ571119A (en) 2006-02-13 2007-02-13 Use of tris(hydroxyquinolinolato)gallium(III) for the treatment of melanomas

Country Status (12)

Country Link
US (1) US7919486B2 (cg-RX-API-DMAC7.html)
EP (1) EP1984005B1 (cg-RX-API-DMAC7.html)
JP (1) JP5210888B2 (cg-RX-API-DMAC7.html)
CN (1) CN101466387A (cg-RX-API-DMAC7.html)
AT (2) AT503317B1 (cg-RX-API-DMAC7.html)
AU (1) AU2007215363A1 (cg-RX-API-DMAC7.html)
CA (1) CA2640509C (cg-RX-API-DMAC7.html)
DE (1) DE502007006880D1 (cg-RX-API-DMAC7.html)
ES (1) ES2365028T3 (cg-RX-API-DMAC7.html)
NZ (1) NZ571119A (cg-RX-API-DMAC7.html)
PT (1) PT1984005E (cg-RX-API-DMAC7.html)
WO (1) WO2007092978A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101783676B1 (ko) * 2010-02-12 2017-10-10 니키 파머 액퀴지션 코포레이션 2 혈액암의 치료 방법
JP2013521229A (ja) * 2010-02-26 2013-06-10 ニッキ ファーマ インク. 脳腫瘍を処置するための方法
CN102946879B (zh) 2010-04-19 2015-04-22 尼基制药公司 一种蛋白酶体抑制剂和镓络合物在制备治疗增殖性疾病的药物中的应用
JP6112512B2 (ja) * 2010-12-01 2017-04-12 レクシ ファーマ インコーポレイテッド 難治性癌を治療するための方法
CN113372269A (zh) * 2021-06-25 2021-09-10 云南大学 一种席夫碱镓配合物及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE166056T1 (de) * 1991-07-25 1998-05-15 Philippe Collery Gallium iii komplexe, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten
DE10113185A1 (de) * 2001-03-19 2002-10-24 Faustus Forschungs Cie Zusammensetzung, enthaltend einen Gallium(III)-Komplex und einen therapeutisch wirksamen Platin-Komplex
DE10116527C2 (de) * 2001-04-03 2003-05-15 Faustus Forschungs Cie Tumorhemmende Galliumverbindungen, deren Verwendung als Arzneimittel sowie ein Arzneimittel, diese enthaltend
AT501819B1 (de) * 2005-04-18 2007-01-15 Faustus Forschung Translationa Verwendung von gallium(iii)-komplexen zur behandlung von tumorerkrankungen der leber

Also Published As

Publication number Publication date
US20090137620A1 (en) 2009-05-28
PT1984005E (pt) 2011-07-11
AU2007215363A1 (en) 2007-08-23
CA2640509A1 (en) 2007-08-23
DE502007006880D1 (de) 2011-05-19
EP1984005B1 (de) 2011-04-06
JP2009525987A (ja) 2009-07-16
CA2640509C (en) 2014-07-08
ES2365028T3 (es) 2011-09-20
WO2007092978A1 (de) 2007-08-23
AT503317A4 (de) 2007-09-15
EP1984005A1 (de) 2008-10-29
US7919486B2 (en) 2011-04-05
CN101466387A (zh) 2009-06-24
ATE504307T1 (de) 2011-04-15
AT503317B1 (de) 2007-09-15
JP5210888B2 (ja) 2013-06-12

Similar Documents

Publication Publication Date Title
JP2009138005A (ja) ルテニウム(iii)錯体および複素環を含む組成物
CA2640509C (en) Use of gallium(iii) complexes for the treatment of melanomas
WO1995028939A1 (en) Medicinal composition as a remedy for nonsmall cell lung cancer
CN110248656B (zh) 一种蓝萼甲素衍生物及其药学上可接受的盐或药物组合物及在制备治疗银屑病药物中的用途
EP3853223B1 (en) Rotomeric isomers of 4-alkyl-5-heteroaryl-3h-1,2- dithiole-3-thiones
US20160096855A1 (en) Method of Treating Colorectal Cancer
CN107334767A (zh) 一种哒嗪酮类化合物在肿瘤治疗中的应用
CN115671107B (zh) 用于解酒的复方药物组合物
AU769882B2 (en) Medicament containing platinum complex compounds and the use thereof
WO2020045461A1 (ja) ピラゾロ[3,4-d]ピリミジン化合物を有効成分とする治療剤
CN103483187B (zh) 4-乙氧基-2-羟基-6-甲基苯甲酸及其药用组合物和应用
AU2013206221A1 (en) Use of gallium (III) complexes for the treatment of melanomas
CN106854223A (zh) 氮芥槲皮素衍生物及其制备方法和用途
CN104606189B (zh) 一种化合物在制备mTOR抑制剂中的应用
HK1129568A (en) Use of gallium(iii) complexes for the treatment of melanomas
CN111494371B (zh) Pyr3的用途
CA2456550A1 (en) Tumour inhibiting cerium compounds
JPH0120128B2 (cg-RX-API-DMAC7.html)
PT1904478E (pt) Sais de adição de ácido de n-etil-n¿-[2-metoxi-4-(5-metil-4- {[(1s)-1-piridin-3-ilbutil]amino}pirimidin-2-il)fenil]ureia e suas utilizações
WO2006110931A1 (de) Verwendung von gallium (iii) komplexen zur behandlung von tumorerkrankungen der leber
BR112020022402B1 (pt) Complexo de ouro(iii), conjugado, composição farmacêutica, uso do complexo de ouro(iii) e processo para a preparação do complexo de ouro(iii)
KR20120101798A (ko) 신규한 6핵 아렌-루테늄 나노 프리즘 케이지 화합물, 이의 제조방법 및 이를 유효성분으로 함유하는 암의 예방 및 치료용 약학적 조성물
JP2004533429A (ja) 腫瘍を阻害するガリウム化合物
BR112020022402A2 (pt) complexo de ouro(iii), seus usos e processo de preparação, conjugado e composição farmacêutica
JPH0137372B2 (cg-RX-API-DMAC7.html)

Legal Events

Date Code Title Description
ASS Change of ownership

Owner name: NIIKI PHARMA INC., US

Free format text: OLD OWNER(S): FAUSTUS FORSCHUNG TRANSLATIONAL DRUG DEVELOPMENT AG

PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 13 FEB 2017 BY COMPUTER PACKAGES INC

Effective date: 20140228

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 13 FEB 2018 BY COMPUTER PACKAGES INC

Effective date: 20170502

LAPS Patent lapsed